Skip to Main Content

Paper Details

SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults.
medRxiv
12
2021
SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 antibodies
Author NameAffiliation
Chloe MirzayiInstitute for Implementation Science in Population Health (ISPH), City University of New York (CUNY) New York City
Chloe MirzayiGraduate School of Public Health and Health Policy, City University of New York (CUNY) New York City
Levi WaldronInstitute for Implementation Science in Population Health (ISPH), City University of New York (CUNY) New York City
Levi WaldronGraduate School of Public Health and Health Policy, City University of New York (CUNY) New York City
Levi WaldronInstitute for Implementation Science in Population Health (ISPH), City University of New York (CUNY) New York City
Levi WaldronGraduate School of Public Health and Health Policy, City University of New York (CUNY) New York City
  • 1 - 6

Datasets

Release 1.2